Prevalence of polycystic ovary syndrome and related disorders in mexican women
- PMID: 20110726
- DOI: 10.1159/000277640
Prevalence of polycystic ovary syndrome and related disorders in mexican women
Abstract
Background/aims: Polycystic ovary syndrome (PCOS) has been found to affect 4-8% of women of reproductive age; however, in Mexican-Americans a prevalence of 12.8% has been reported. This study determines the prevalence of PCOS in a sample of Mexican women.
Methods: This prospective cross-sectional study included 150 female Mexican volunteers aged 20-45 years. Menstrual cycles were recorded and hirsutism was graded. Pelvic ultrasound was performed and androgen levels were measured. PCOS was diagnosed by hyperandrogenism and/or hyperandrogenemia, and oligo-ovulation (NIH 1990 criteria), and also by 2 of 3 findings: oligo-ovulation, clinical and/or biochemical hyperandrogenism and polycystic ovaries (PCO) (Rotterdam 2003 criteria), excluding other disorders.
Results: Nine of the 150 women were diagnosed with PCOS, a prevalence of 6.0% (95% CI: 1.9-10.1%), according to NIH criteria. The ultrasound morphology added one patient to give ten PCOS patients, a prevalence of 6.6% (95% CI: 2.3-10.9%) according to Rotterdam criteria. All PCOS patients presented oligo-ovulation, 9 had hirsutism and 7 of them had acne. Eight of the 10 PCOS patients had morphologic characteristics of PCO.
Conclusion: The prevalence of PCOS in Mexican women is approximately 6.0%, similar to other populations, but lower than 12.8% reported in Mexican-American women.
Copyright (c) 2010 S. Karger AG, Basel.
Similar articles
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC. Endocr Pract. 2015. PMID: 26509855
-
Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.J Cosmet Dermatol. 2018 Jun;17(3):511-517. doi: 10.1111/jocd.12387. Epub 2017 Sep 21. J Cosmet Dermatol. 2018. PMID: 28940857
-
Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.JAMA Dermatol. 2016 Apr;152(4):391-8. doi: 10.1001/jamadermatol.2015.4498. JAMA Dermatol. 2016. PMID: 26720591
-
Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis.Hum Reprod Update. 2022 Jun 30;28(4):501-517. doi: 10.1093/humupd/dmac011. Hum Reprod Update. 2022. PMID: 35237802
-
Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis.Hum Reprod Update. 2018 Nov 1;24(6):694-709. doi: 10.1093/humupd/dmy022. Hum Reprod Update. 2018. PMID: 30059968
Cited by
-
[Proinflammatory cytokines in polycystic ovarian syndrome].Rev Med Inst Mex Seguro Soc. 2022 Aug 31;60(5):569-576. Rev Med Inst Mex Seguro Soc. 2022. PMID: 36049035 Free PMC article. Review. Spanish.
-
Environmentally induced epigenetic transgenerational inheritance of ovarian disease.PLoS One. 2012;7(5):e36129. doi: 10.1371/journal.pone.0036129. Epub 2012 May 3. PLoS One. 2012. PMID: 22570695 Free PMC article.
-
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.Nat Rev Endocrinol. 2011 Apr;7(4):219-31. doi: 10.1038/nrendo.2010.217. Epub 2011 Jan 25. Nat Rev Endocrinol. 2011. PMID: 21263450 Review.
-
Prevalence of Hirsutism Among Reproductive-Aged African American Women.J Womens Health (Larchmt). 2021 Nov;30(11):1580-1587. doi: 10.1089/jwh.2021.0125. Epub 2021 Sep 14. J Womens Health (Larchmt). 2021. PMID: 34520248 Free PMC article.
-
Evaluating compliance to a low glycaemic index (GI) diet in women with polycystic ovary syndrome (PCOS).BMC Res Notes. 2011 Mar 8;4:53. doi: 10.1186/1756-0500-4-53. BMC Res Notes. 2011. PMID: 21385417 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical